Bank of New York Mellon’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-526,655
| Closed | -$15.1M | – | 4296 |
|
|
2018
Q4 | $15.1M | Sell |
526,655
-72,915
| -12% | -$2.07M | ﹤0.01% | 1668 |
|
|
2018
Q3 | $16.7M | Sell |
599,570
-5,700
| -0.9% | -$160K | ﹤0.01% | 1727 |
|
|
2018
Q2 | $16.9M | Buy |
605,270
+29,934
| +5% | +$803K | ﹤0.01% | 1703 |
|
|
2018
Q1 | $14.3M | Sell |
575,336
-6,987
| -1% | -$170K | ﹤0.01% | 1790 |
|
|
2017
Q4 | $14.1M | Buy |
582,323
+19,086
| +3% | +$503K | ﹤0.01% | 1801 |
|
|
2017
Q3 | $15.5M | Sell |
563,237
-24,759
| -4% | -$660K | ﹤0.01% | 1726 |
|
|
2017
Q2 | $14.7M | Sell |
587,996
-51,870
| -8% | -$1.28M | ﹤0.01% | 1736 |
|
|
2017
Q1 | $17.2M | Buy |
639,866
+2,914
| +0.5% | +$80.5K | ﹤0.01% | 1637 |
|
|
2016
Q4 | $16.7M | Sell |
636,952
-23,016
| -3% | -$569K | ﹤0.01% | 1656 |
|
|
2016
Q3 | $16.5M | Sell |
659,968
-44,795
| -6% | -$1.04M | ﹤0.01% | 1568 |
|
|
2016
Q2 | $15.3M | Sell |
704,763
-30,443
| -4% | -$543K | ﹤0.01% | 1588 |
|
|
2016
Q1 | $11M | Buy |
735,206
+34,227
| +5% | +$574K | ﹤0.01% | 1786 |
|
|
2015
Q4 | $15.4M | Sell |
700,979
-24,242
| -3% | -$452K | ﹤0.01% | 1573 |
|
|
2015
Q3 | $11.4M | Buy |
725,221
+387,688
| +115% | +$6.22M | ﹤0.01% | 1783 |
|
|
2015
Q2 | $4.82M | Buy |
337,533
+16,486
| +5% | +$279K | ﹤0.01% | 2378 |
|
|
2015
Q1 | $5.55M | Buy |
321,047
+5,320
| +2% | +$94K | ﹤0.01% | 2258 |
|
|
2014
Q4 | $5.66M | Buy |
315,727
+2,655
| +0.8% | +$42.8K | ﹤0.01% | 2253 |
|
|
2014
Q3 | $4.11M | Buy |
313,072
+19,562
| +7% | +$263K | ﹤0.01% | 2431 |
|
|
2014
Q2 | $4.22M | Sell |
293,510
-4,402
| -1% | -$57.5K | ﹤0.01% | 2418 |
|
|
2014
Q1 | $3.8M | Buy |
297,912
+380
| +0.1% | +$4.96K | ﹤0.01% | 2456 |
|
|
2013
Q4 | $2.98M | Sell |
297,532
-3,397
| -1% | -$38.6K | ﹤0.01% | 2626 |
|
|
2013
Q3 | $3.96M | Sell |
300,929
-17,507
| -5% | -$230K | ﹤0.01% | 2380 |
|
|
2013
Q2 | $4.55M | Buy |
+318,436
| New | +$4M | ﹤0.01% | 2237 |
|
Other funds holding NXTM
Bank of New York Mellon's NXTM Position: Q1 2019 in Review
Bank of New York Mellon sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 526,655 shares — an estimated $15.1M sold.
Bank of New York Mellon first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $17.2M in Q1 2017. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.
- Bank of New York Mellon reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
- Bank of New York Mellon sold 526,655 NxStage Medical Inc. shares in Q1 2019, an estimated $15.1M.
- Bank of New York Mellon first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
- Bank of New York Mellon's NxStage Medical Inc. position peaked at $17.2M in Q1 2017.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.
Based on Bank of New York Mellon's 13F filing for Q1 2019, filed 14 May 2019.